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ABST RACT
Acute pancreatitis is an acute inflammatory process of the pancreas,
which can remain localized at the level of the gland or can extend to the
peripancreatic and retroperitoneal tissues. The use and interpretation of
paraclinical examinations at the onset can predict the form of evolution
of acute pancreatitis (mild or severe). Depending on the evolution, these
data are useful in determining the type of surgical intervention that
might be necessary based on severity.
We present a retrospective study consisting of 118 patients diagnosed
and hospitalized with acute pancreatitis during 2016-2020 in the Surgery
I section of the Sibiu County Emergency Clinical Hospital. Several
parameters were taken into account at hospitalization such as age, sex,
the environment of origin, etiology of pancreatitis, biochemical
parameters with their repetition at 24, 72 hours, and at discharge, and
clinical signs at hospitalization. surgeries performed depending on the
severity of pancreatitis specifying their complications.

Introduction
Acute pancreatitis is described by Dieulafoy as the
"great abdominal drama", being a complex pathology with
multifactorial etiology, diagnostic difficulties, evolution
that causes functional repercussions on the body and with
a treatment that does not correspond to a clear protocol [1].
The latest research and discussions on the diagnosis and
treatment of acute pancreatitis are focused on solving some
major problems, one of them being the establishment of the
indication and the optimal time for surgery, the therapeutic
strategy for severe cases and the evaluation of local
complications. Global mortality from pancreatitis
increased by 64.8% between 1990 and 2019 [2]. In
Romania, the incidence of pancreatitis is 40-50,000 to
100,000 people per year, with a distribution of 25-30% in
the Ardeal region and a mortality of 30-40% [3].
The cost of medical care for patients suffering from
acute pancreatitis is directly proportional to the length of
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hospitalization, plus the total costs of medical and surgical
treatment, where necessary, and paraclinical investigations
performed.
The rapid and effective diagnosis of acute pancreatitis
on admission is very important for the prescription of a
personalized treatment for each patient depending on the
type of pancreatitis (acute or severe) and the complications
that have occurred [4].
Multiple specialized studies use the values of
hemoglobin, hematocrit, leukocytes, creatinine and
pancreatic enzymes as predictive factors for assessing the
severity of acute pancreatitis, obtaining positive statistical
results by using these parameters.

Materials and Methods
This is a retrospective study from January 2006 to
December 2020 on a set of 118 patients diagnosed in the
emergency room and admitted to the general surgery
department with acute pancreatitis. Proper handling of
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personal protective equipment (PPE) and adherence to
hygiene rules were carefully observed for inpatients during
the COVID-19 pandemic to prevent contamination of staff
and other inpatients [5].
Several parameters were monitored, among which we
list those of significant value for our study: age, sex,
environment, hemoglobin value upon admission and after
72 hours, hematocrit value upon admission and after 24
hours, the value of leukocytes upon admission and in
evolution up to discharge, the value of pancreatic amylase
upon admission and in evolution up to discharge. In terms
of imaging studies, the following parameters were
monitored: abdominal ultrasonography, plain chest and
abdominal radiography, and computed tomography with
calculation of the Balthazar score. Apache and Ranson
scores were calculated for the 118 patients.
The severity of the form of acute pancreatitis
presented by the patients in our study was established
according to the calculation of the Apache, Ranson scores,
as well as by the calculation of the Balthazar score after
performing the computed tomography.
Patients diagnosed with acute pancreatitis hospitalized
and treated in other medical departments, patients suffering
from chronic pancreatitis, and patients with severe acute
pancreatitis in critical condition who died within the first
24 hours were excluded from the study. For patients
admitted during the Covid-19 pandemic, all precautions to
prevent spread in the hospital have been taken.
The general group contains 118 patients divided into
three groups. Group A includes patients who underwent
conservative treatment of acute pancreatitis and consists of
28 patients (23.72%). Group B includes patients who
benefited from the protocol of the surgical therapeutic
window for acute pancreatitis and consists of 60 patients
(50.84%). Group C includes patients who underwent
surgical treatment for complications of acute pancreatitis
and consists of 30 patients (25.42%).
The data used in this study were collected from patient
records. Such data were represented by general information
(age, sex, family medical history, associated diseases,
the way the disease started, weight), clinical data
(clinical signs and symptoms), laboratory data (upon
admission, during the evolution of the disease,
preoperative and postoperative), imaging investigations
(echography, pulmonary x-ray, abdominal x-ray, computer
tomography), intraoperative data (extension of pancreatic
peripancreatic necrosis, the condition of the gallbladder
and of extrahepatic bile ducts, the existence of pathological
fluids which should be sampled for culture and
antibiogram, associated visceral injuries), treatment
(conservative, minimally invasive and surgically open),
therapeutic results (recovery, complications, recurrences,
death).
The minimally invasive/ laparoscopic surgical
interventions proposed and performed on group B patients

was analyzed from several points of view: the timing of the
operation, the location of the necrosis in necrotizing
pancreatitis, the length of stay, reinterventions,
postoperative complications and deaths. The collection of
all these data highlighted the value of laparoscopic
treatment in acute pancreatitis.
The resulting data has been processed on the computer,
by using the set of statistical applications Microsoft Excel
and MedCalc. For the graphic illustration of the obtained
results, the data were presented in tables and graphs. The
quantity variables are presented at medium value and with
intervals (± limits). The Mann-Whitney test, the t Student
test, p<0.05 have been used for comparisons between
analysis groups. The chi-square or x² test has been used for
value association.

Results
Most of the patients included in the study group were
males (75, 63%) and from rural area (72%). The age of the
general lot ranges from 20 to 75 years, with a medium age
of 53.2+/-9.8 years (Table 1). Most frequent associated
comorbidities were arterial hypertension (38.1%),
ischemic cardiac disease (19.5%), and diabetes (11%).
Table 1. General characteristics of the patients in the
study group.
Parameter

No of cases (%)

AP etiology:
Biliary
Alcoholic
Metabolic
Posttraumatic
After surgery
Idiopathic

53(44.9%)
37 (31.3%)
6 (5%)
2 (1.6%)
9 (7.6%)
11(9.3%)

Comorbidities:
Arterial hypertension
Diabetes
Ischemic cardiac diseases
Respiratory diseases

45(38.1%)
13(11%)
23(19.5%)
5 (4.2%)

Time elapsed since the onset of
symptoms:
24-48 h
48-72 h
3-5 days
5-7 days

5 (4.3%)
47(39.8%)
35 (29.6%)
31 (26.3%)

AP form:
Mild
Severe

86 (72.8%)
32 (27.2%)
The classification by levels of severity was achieved by
following the Atlanta criteria, respectively one or more of
the following criteria: Glasgow score at admission ≥ 3
(recalculated after 48 hours); Apache II score ≥ 8 (during
disease progression); the presence of one or more organ
dysfunctions (shock, multiple organ failure, acute renal
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failure, upper digestive hemorrhage, disseminated
intravascular coagulation); the presence of one or more
local complications (abscess, necrosis or pancreatic
pseudocyst).
Regarding the severity of pancreatitis, 86 pancreatitis
were mild forms (72.88%) and 32 pancreatitis were severe
forms (27.11%).
According to our study, the frequency of alcoholinduced acute pancreatitis is 30% and has the highest
incidence among male patients, and that of biliary
pancreatitis is 45% and is more common in women.
The clinical picture was dominated by the main
symptom, that is abdominal pain on both sides, present in
118 (100%) patients. The type of pain has been described
as long-lasting, in some cases even resisting even strong
analgesic drugs, requiring the installation of an epidural
catheter. Dyspeptic syndrome characterized by nausea and
vomiting was present in 110 (93.22%) patients. Paralytic
ileus caused by excruciating abdominal pain was
experienced by 75 (63.55%) patients. The presence of a

palpable abdominal formation has been present in 24
(20.33%) patients. The acute surgical abdomen has been
present in 28 (23.72%) patients. Fever has been
experienced in 36 (30.5%) cases while tachycardia in 85
(72%) cases. Superior digestive hemorrhage manifested as
hematemesis and melena has been recorded in 7 (5.93%)
cases, being associated to shock or severe sepsis.
Clinical examination by palpation revealed epigastric
abdominal pain radiating to both sides in 118 cases (100%).
Twenty-eight patients have presented signs of acute
surgical abdomen, sensitivity in Mallet-Guy and positive
Mayo-Robson points was present in 74 patients (62.71%).
Abdominal ecchymoses were present in 4 patients as
Cullen (periumbilical ecchymoses) and Gray-Turner (flank
ecchymoses) signs.
In our study, 23 patients out of 32 presented severe
pancreatitis, compared to 18 out of 86 suffering from mild
acute pancreatitis with the hematocrit > 46% upon
admission. The hematocrit value has been calculated upon
admission for all patients (Table 2).

Table 2. Clinical, biological and imagistic parameters in patients in the study group.
Mild form (n=86)
Ht. at admission
Ht. at 24 h
Hb. at admission
(mg/dl)
Hb. at 72 h
Leukocytes at
admission (e/dl)

18
24
10-12 12-14 14-16

8-10

Sever form (n=32)

>16

8-10

10-12

23
8
12-14

Total

14-16

>16

1

5

52

26

2

17

6

9

0

0

0

0

83

3

0

0

9

22

1

0

40009000

9000- 10000- 15000- 4000- 9000- 10000- 15000>20000
10000 150000 20000 9000 10000 15000 20000

8

3

53

22

0

0

2

8

22

Leukocytes
at 72 h

17

43

19

7

0

4

5

8

15

Leukocytes at
discharge

67

19

0

0

25

5

2

0

0

Amylases at
admission

<25 u/l
2

25-125 u/l
20

3x125 u/l
37

5x125u/l
59

Creatinine at
admission

<1.8 mg/dl

>1.8 mg/dl

<1.8 mg/dl

>1.8 mg/dl

19

39

15

12

<1.8 mg/dl
71

>1.8 mg/dl
15

<1.8 mg/dl
11

>1.8 mg/dl
21

Creatinine at 48 h

p

41
32

The hemoconcentration has been recorded as Ht. > 46%
for men and > 42% for women. The medium value of the
hematocrit has been 40±5% for women and 44±6% for men
(p<0.01). Hematocrit values increased from 21% to 72% in
patients who had mild or severe pancreatitis. Thus,
hematocrit was determined in 104 (88%) patients in the
first 24 hours after admission. Of these, 75 (64%) patients
had mild forms of pancreatitis and 29 (24%) patients had
severe forms of pancreatitis.
312

118

85

<0.001

118

<0.0001

In 28 patients from the 86 suffering from mild acute
pancreatitis the hemoglobin has a high value as a result of
the hemoconcentration which accompanies vomiting and
fluid sequestration due to third spacing.
Upon admission, 17 patients have presented a major
decrease in hemoglobin levels determined by the sanguine
effusion on patients with severe acute pancreatitis. In the
case of our study a relatively high decrease of hemoglobin
levels has been recorded 72 hours from admission in severe
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acute pancreatitis, being associated to the hemorrhages
from the pancreatic lodge or to the transfer of sanguine
mass to the splanchnic area, caused by states of shock.
In the cases of mild acute pancreatitis, our study shows
a leukocyte value ranging from 15,000 to 20,000 in 22
patients with a reduction in their dynamics. Upon discharge
we observed that 67 patients had a normal leukocyte value
ranging from 4,000 to 9,000 elements/dl.
In the cases of severe acute pancreatitis, we have
observed that 22 patients have, upon admission, a
leukocyte value over 20,000 elements/dl, with a decrease
in their level down to the normal value. 32 patients have
been discharged with a normal leukocyte value.
Creatinine value has been recorded for 85 patients upon
admission and 48 hours after admission for 118 patients.
The p value regarding the relation between creatinine and
acute pancreatitis severity with a value of p < 0.001 upon
admission and 48 hours afterwards, shows a value with
high statistical significance regarding the relation between
the values of creatinine that exceed 1.8 mg/dl and the
severity of acute pancreatitis.
In 48 hours from the admission the creatinine value has
been calculated for all the patients in the total study group,
observing that 13 out of 15 patients with creatinine values >
1.8 mg/dl have developed necrotizing pancreatitis.
From the total lot of 118 patients diagnosed with acute
pancreatitis, the amylase values have been lower than
normal values in 2 cases, lacking significance for
diagnosis. In 20 cases, the amylase value was normal, in 37
cases it was 3 times higher than the normal values, while
in 59 cases the amylase value was 5 times higher than
normal values.
All patients underwent abdominal X-ray and chest Xray at admission. Computer tomography has been
recommended for diagnosis and monitoring, as well as in
the cases where the clinical symptomatology and
biochemical results have been inconclusive. This
investigation was carried out in all cases, to evaluate the
severity of the current episode of acute pancreatitis. It has
identified n=53 (45%) cases in stages A and B
corresponding to mild pancreatitis according to Balthazar’s
classification. In stages C, D, E (corresponding to severe
pancreatitis) patients were identified and grouped as
follows: n=19 (16%) cases in stage C, n=31 (26%) in stage
D and 15 cases (12%) in the E stage.
According to Ranson criteria, 32 patients have been
diagnosed with severe acute pancreatitis, score ≥ 3, but
still, only 14 of them have developed local and general
complications (as a result of data collection from
other diagnosis criteria related to acute pancreatitis).
By analyzing the Table 2, it can be observed that the
Apache II score has a better specificity and positive
predictive value than the Ranson score, but having, at the
same time an equal negative predictive value.

Table 3. Value of Ranson criteria calculated to predict
the severity of acute pancreatitis in the study group
Criteria Sensitivity Specificity VPP VPN

p-value

Age
Leukocyte

0.50
0.61
0.12 0.89
0.02*
0.40
0.82
0.22 0.83
0.06
Glucose
0.12
0.72
0.21 0.82
0.32
ASAT
0.21
0.63
0.07 0.82
0.83
Hematocrit
0.22
0.63
0.10 0.82
0.60
Calcium
0.52
0.81
0.27 0.90
0.02*
Urea
0.22
0.83
0.31 0.90
0.08
PaO2
0.58
0.64
0.37 0.85
0.07
Footnote: VPP-positive predictive value, VPN-negative
predictive value, *statistically significant at p<0.05
The mean value of Ranson score was of 1.70+/-1.23 in
the mild acute pancreatitis group, and of 3.73±1.80 in the
severe acute pancreatitis group (p<0.0001). The value of
Apache II score at 24 h after admission was 7.62±3.49 for
mild and 9.47±4.25 in severe acute pancreatitis group
(p<0.004). Statistical analysis showed a similar sensitivity
and negative predictive value for the two score systems in
acute pancreatitis, with a slightly higher specificity (75 vs
68%) and positive predictive value (54% vs 37%) for the
Apache II score at 24 hours versus Ranson score in
predicting the severity in the study group.
Table 4. Comparison of predictive values between
Ranson score and Apache II
Parameter

Ranson

Apache II 24 h

Sensitivity
Specificity
Positive predictive value

81%
68%
37%

81%
75%
45%

Negative predictive value
P value

95%
<0.001

95%
<0.001

Informing patients about the therapeutic options,
complications and outcomes is particularly important, as
they will become an active partner in the patient-physician
relationship in preoperative training and postoperative care
[6]. In the study group, the patients were treated according
to the international guidelines for acute pancreatitis. Only
biliary pancreatitis were considered a surgical indication
from the beginning. For the other etiologies, surgery was
decided when local complications were documented under
adequate medical treatment. Laparoscopy allow an
exploration of the peritoneal cavity, with staging of
pancreatitis, sampling of pancreatic ascites, evaluation of
cytosteatonecrosis and pancreatic necrosis. The minimal
invasive approach also permits biliopancreatic
decompression by cholecystostomy, contact vagolysis by
laparoscopic insertion of a periesophageal catheter,
continuous capsular analgesia by administration of contact
anesthetics. As radical indications, we performed
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laparoscopic drainage of the peripancreatic collections
with lavage-drainage, necrectomies being performed in
laparoscopically selected cases, if not performed by open
surgery and pathogenic treatment. In advanced cases,
drainage of the omental bursa may be performed through
the gastrocolic ligament section and necrectomy in necrotic
pancreatitis. Drainage and continuous postoperative lavage
are performed with large caliber tubes to allow the
evacuation of purulent secretions and sphaceli, with saline,
lactic acid. In order to allow the approach and exploration
of the whole pancreas, the alternative insertion of the
working channel telescope can be performed in all three 15
mm trocars (supraumbilical, epigastric and on the right
flank, facilitating the direct access to the necrotic body
and tail pancreatic areas. 77 interventions/ reinterventions
were performed on the 60 patients out the 118 in the study
group (50.8%).
The average hospital days were of 13.2+/-10.7 days,
with variations between 7 and 34 days. The ICU hospital
days were of 7.6 +/-8.2 days (5-22 days).
Local complications were present in 21 cases, being
represented by pancreatic abscesses (10 cases), pancreatic
fistulas (5 cases), ileus (3 cases), pancreatic pseudocysts (4
cases) and hemorrhages from the omental bursa in 2 cases
(after performing pancreatic necrectomies, that were
solved by laparoscopic hemostasis). Pancreatic
pseudocysts were solved in 3 cases an external drainage
performed laparoscopically, and the other had a favorable
evolution by conservative treatment (no surgical treatment
being necessary).
General complications occurred in 21 patients, being
represented by upper digestive hemorrhage in 2 cases,
respiratory failure in 2 cases, pleurisy in 3 cases, acute
renal failure in one case, pulmonary embolism in one case,
MSOF in 12 cases. Mortality in the study group was 14.4%
(17 cases). The data analysis reveals that the patients who
died were older and had greater APACHE II scores upon
admission. The experienced surgical team(s), good
communication between ICU and surgical departments,
proactive management of co-morbidities and hydroelectrolytic imbalance, as well as implementing clinical
protocols are currently considered key elements to increase
patient safety and provide better outcomes [7].

Discussion
The increased number of severe pancreatitis cases in
the studied group, compared to those from the literature
(80% being mild acute pancreatitis and 20% being severe)
is due to the increased use of alcohol in our country and
delayed presentation of the patients from rural areas. In
addition, such severe forms of pancreatitis could also be a
result of the development of diagnosis procedures and of
the experience accumulated in the field of diagnosis and
treatment of this type of pathology [8].
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The literature indicates a frequency of biliary acute
pancreatitis ranging between 35 and 49%, and a percentage
of approximately 20% for alcohol-induced pancreatitis [9].
In our study, the most frequent causes were also biliary and
alcoholic. However, we identified an important percentage
(about 10%) that is represented by idiopathic acute
pancreatitis, while 15% is represented by pancreatitis
caused by other factors. The absence of a gold standard for
the diagnosis of this disease can explain the increased
frequency of acute pancreatitis of unknown etiology and
thus makes it difficult to evaluate several tests proposed for
the diagnosis [10,11].
According to our study, pain is a symptom found in all
patients in the investigated group and may in some cases
mimic different causes of acute surgical abdomen. It
can be accompanied by shock phenomena, such as
perforated peptic ulcer, mesenteric ischemia, bowel
occlusion, acute cholecystitis, acute appendicitis or
Amyand`s hernia [12-15].
The increase in hemoglobin and hematocrit values in
45-50% of the patients with acute pancreatitis is a variation
that is due to blood hemoconcentration resulting from
vomiting as well as fluid sequestration in the third spacing,
such data being also confirmed in our study [16]. The
dehydration which produces hemoconcentration is a
factor which appears to contribute to pancreatic necrosis
and organ failure [17]. If the hematocrit is 45-50% or
greater upon admission and no improvement is recorded in
the first 24 hours, the probability to develop a necrotizing
pancreatitis increases significantly (sensitivity of 81%,
specificity of 88%) [18,19].
Gray and Rosenman showed in 1965 that the
hemoconcentration upon admission had no prognosis value
in patients suffering from acute pancreatitis [20]. Talamini
et al. found no significant differences between 24-hour
hematocrit levels in patients with acute pancreatitis and in
patients who died of this condition [21]. On the other hand,
the Ranson study shows that a greater than 10% reduction
in the first 48 hours of therapy is correlated with a decrease
in severity and mortality.
Remes and Duarte published results similar to those
obtained in our study, but applied to a larger number of
patients and calculating the prognosis according to organ
failure and intrapancreatic extension of the areas of
necrosis [22,23]. In this study we found that patients with
no hemoconcentration have low chances of developing
pancreatic necrosis or organ failure.
Leukocytosis > 16,000 mm³ is significant both in
statistical p < 0.001 and percentage terms for patients
suffering from severe pancreatitis at 72 hours, n=22 (68%).
The high level of creatinine values is known as a negative
prognosis factor in acute pancreatitis. High creatinine values
recorded at 48 hours from admission have been recently
described as an indicator of pancreatic necrosis [24].
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Our study suggests that creatinine values higher than
1.8 mg/dl recorded 48 hours after admission are closely
correlated with the development of pancreatic necrosis,
with a positive predictive value of 89%. Similar values
have been presented in other studies, such as Muddana's
data showing a VPP of 93% [25]. In correlation with
pleural effusion, it is a useful factor for the prognosis of
severity in the first 24 hours.
The data from the global statistics of several published
studies have revealed that the serum amylase sensitivity in
the diagnosis of acute pancreatitis is 83% (ranging between
81% and 85%). Pancreatic amylase has a sensitivity close
to that of lipase (95%), both of them having a sensitivity
which is significantly higher than that of total amylase in
the diagnosis of acute pancreatitis [26].
Imaging explorations provide valuable information
regarding the etiology and local complications of acute
pancreatitis [27]. Plain abdominal x-ray had small
contribution to the diagnosis of acute pancreatitis, but was
mandatory in cases requiring emergency differential
diagnosis when CT examination was unavailable or
contraindicated [28]. Pulmonary x-ray has been used
routinely for the identification of pleural collections or of
pulmonary infiltrates. Pleurisy is strongly correlated to
severe pancreatitis, being encountered in our study in n=30
(26%) cases. In correlation with creatinine value, it is a
useful factor for the prognosis of severity in the first 24
hours. The benefit of abdominal radiography and
ultrasound is represented by the discovery of vesicular
stones, the appearance of changes in the main bile duct,
monitoring the evolution of pancreatic and peripancreatic
pathological collections [29].
Computed tomography is one of the essential imaging
techniques for staging and early detection of complications
of acute pancreatitis. It has a sensitivity of around 87% and
a detection rate of pancreatic necrosis of over 90%, data
that correspond to the results of our study [30-32].
The evolutive spread of the necrosis has been correlated
with the increase in morbidity and mortality. In patients
without necrosis the mortality rate is approximately 0%
and the morbidity is around 5%, while the presence of 50%
necrosis resulted in a 25% mortality rate within the group
and a 75% morbidity. In the group that developed necrosis
over 50% there was a mortality of 10% and a morbidity of
100% (33).
The study revealed that the Apache II test is not
significantly different from the Ranson scoring system in
predicting the severity of acute pancreatitis. The result
obtained in our study are similar to those published in the
literature, with values ranging from 67% to 93% [31-33].
Mortality rates have recorded statistically significant
difference between the patients treated with minimally
invasive techniques and the ones treated with conservative
techniques or open surgeries. The factors which have
influenced the survival are represented by age (p < 0.05),

APACHE II scoring upon admission (p < 0.01) and the
presence of multiple organ disfunction (p < 0.001) [33].
Long term follow-up of the patients with acute
pancreatitis is important, not only for documentation of the
local complication (pancreatic pseudocysts or fistulas) but
also for metabolic status [34-38]. Abdominal pain causing
decreased oral intake, as well as exocrine and endocrine
insufficiency are frequent complications of the disease
[34]. Therefore, all patients with acute or chronic
pancreatitis should be screened for malnutrition.
Significant weight loss may impose differential diagnosis
with gastrointestinal cancer, by superior endoscopic and
colonoscopy screening [39,40]. Large abdominal surgeries
for pancreatitis related complications, such as necrotic
collections may lead to long term postoperative issues
related to intraperitoneal adherences due to imbalance
between fibrinolytic activity and adhesiogenesis [41].
It well recognized the bidirectional relationship
between acute pancreatitis and diabetes. On one hand, there
is an increased baseline inflammation level in patients with
diabetes, leading to several disfunctions in immune
response induced by endogen and exogen triggers [40].
Several studies found that diabetes is a risk factor for
severe acute pancreatitis [42]. On the other hand,
destructions in the pancreatic tissue may lead to diabetes
after acute pancreatitis [35,36].

Conclusions
Early and accurate staging of the severity of acute
pancreatitis should be performed through a careful clinical
evaluation, and in severe clinical forms, computed
tomography, Ranson score and APACHE II should be
used. Regular clinical assessment is extremely important
and must not be underestimated in medical practice, since
it supplies additional information concerning the evolution
of the disease.
The factors which correlate with severe forms of acute
pancreatitis are age, pain, hematocrit, hemoglobin,
leukocytes, urea, creatinine, which present a satisfactory
statistical significance.
The mortality rate is influenced by the age of patients
and the associated complications and comorbidities (more
than by the various disease etiologies), being directly
proportional to the severity of complications.
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